 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Madopar is a drug used to control Parkinson’s disease. Its major components are Levodopa and Benserazide. Levodopa is the precursor to dopamine. It can cross the blood-brain barrier to get into the brain and is then converted to dopamine through decarboxylation to exert effects. Dopamine is one of the neurotransmitters in the brain and patients with Parkinson’s disease just have a deficiency of dopamine in the basal ganglia. Levodopa is usually used in combination with a peripheral decarboxylase inhibitor (such as carbidopa or beserazide) to decrease the peripheral decarboxylation of Levodopa before reaching the brain and thus extend the time it works. When taken with protein-rich food, the therapeutic effect of Madopar will be reduced. The side effects of Madopar include symptoms of dizziness, uncoordinated movement, difficulty swallowing, an abnormally fast resting heart rate (tachycardia), cardiac arrhythmia, nausea, vomiting, fever, sweating, drowsiness, insomnia, confusion, psychiatric disorders, seizures, muscle stiffness, and blurred vision associated with halos around sources of light, etc. In 1989, Mr. Yuan Lin discovered the Absolutely Constant Energy Source (ACES). He can utilize ACES to activate the genome responsible for inheritance, development and performance of body functions in the human body to control specific amino acid sequences and protein peptide chain formation processes, directing cell division, replication and new organelle formation. ACES was also applied to induce changes in the irreversible process of spontaneous biochemical reactions of carbohydrates, lipids, proteins, amino acids, enzymes, nucleic acids, vitamins, hormones, and trace elements. Mr. Yuan Lin thus had his body experience an unprecedented leap forward in human evolution, which has thoroughly changed the human biological form, structure, and habits inherited over billions of years, to become the first successfully-evolved New Human Line.
The purpose of this experiment is to prove that Mr. Yuan Lin, the first successfully-evolved New Human Line, can utilize the Absolutely Constant Energy Source (ACES) and the new biological engineering techniques to activate Madopar and change its concentration without any change in its molecular weight, structural formula, and conformation, at 25℃, 1.0 atm, and pH 7.0, in a confined and isolated space, and with no contact with catalysts, biologically active substances, chemical substances, and physical action forces, and also, by means of changes in the concentration, to control the biochemical reactions induced by Madopar so as to maximize its efficacy in the human body at the lowest dose, reduce or totally eliminate the side effects, and avoid adverse medical reactions. Table 1. Comparison of the absorbance between two treatments at 278 nm From the above experimental results, we can see that there is significant difference (p=0.05) in the concentration between the control samples and the samples treated with ACES by Mr. Yuan Lin. It proved that Mr. Yuan Lin, the New Human Line, can utilize the Absolutely Constant Energy Source and the new biological engineering techniques to activate Madopar and change its concentration, and also, by means of changes in the concentration, to control the biochemical reactions induced by Madopar so as to maximize its efficacy in the human body at the lowest dose, reduce or totally eliminate the side effects, and avoid adverse medical reactions.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
